Erratum: Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area (JAMA - Journal of the American Medical Association (2020) DOI: 10.1001/jama.2020.6775);Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area

JAMA - Journal of the American Medical Association

Volumn 323, Issue 20, 2020, Pages 2052-2059

  Richardson, Safiya ^a   Hirsch, Jamie S ^a   Narasimhan, Mangala ^a   Crawford, James M ^a   McGinn, Thomas ^a   Davidson, Karina W ^a   Barnaby, Douglas P ^a   Becker, Lance B ^a   Chelico, John D ^a   Cohen, Stuart L ^a   Cookingham, Jennifer ^a   Coppa, Kevin ^a   Diefenbach, Michael A ^a   Dominello, Andrew J ^a   Duer Hefele, Joan ^a   Falzon, Louise ^a   Gitlin, Jordan ^a   Hajizadeh, Negin ^a   Harvin, Tiffany G ^a   Hirschwerk, David A ^a   Kim, Eun Ji ^a   Kozel, Zachary M ^a   Marrast, Lyndonna M ^a   Mogavero, Jazmin N ^a   Osorio, Gabrielle A ^a   Qiu, Michael ^a   Zanos, Theodoros P ^a   more..

^a Northwell Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGE; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL FEATURE; COMORBIDITY; CORONAVIRUS DISEASE 2019; DEMOGRAPHY; DIABETES MELLITUS; DYSPNEA; EMERGENCY HEALTH SERVICE; FEMALE; FEVER; FOLLOW UP; HEALTH CARE SYSTEM; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPERTENSION; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEW YORK; NEWBORN; OBESITY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; SCHOOL CHILD; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SURVIVAL RATE; TACHYPNEA; THROAT CULTURE; VITAL SIGN; YOUNG ADULT; AGED; BETACORONAVIRUS; COMPLICATION; CORONAVIRUS INFECTION; DIABETIC COMPLICATION; HOSPITALIZATION; PANDEMIC; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETACORONAVIRUS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CORONAVIRUS INFECTIONS; DIABETES COMPLICATIONS; FEMALE; HOSPITALIZATION; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW YORK CITY; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85084133173     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2020.7681     Document Type: Erratum

References (13)

1. Holshue ML, DeBolt C, Lindquist S,; Washington State 2019-nCoV Case Investigation Team. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382 (10): 929-936. doi: 10.1056/NEJMoa2001191 32004427
2. The Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Coronavirus COVID-19 global cases. Accessed March 30, 2020. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
3. Centers for Disease Control and Prevention. Coronavirus disease 2019 (COVID-19): cases in US. Accessed March 25, 2020. https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html
4. Zhou F, Yu T, Du R, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3 32171076
5. United Nations Department of Economic and Social Affairs Population Dynamics. World population prospects 2019. Accessed April 6, 2020. https://population.un.org/wpp/Graphs/DemographicProfiles/Pyramid/840
6. Chen Z, Peto R, Zhou M,; China Kadoorie Biobank (CKB) collaborative group. Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet. 2015; 386 (10002): 1447-1456. doi: 10.1016/S0140-6736(15)00340-2 26466050
7. Institute for Health Metrics and Evaluation. GBD Compare/Viz Hub. Accessed April 6, 2020. https://vizhub.healthdata.org/gbd-compare/
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40 (5): 373-383. doi: 10.1016/0021-9681(87)90171-8 3558716
9. Kellum JA, Lameire N, Aspelin P, Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2 (1): 1-138.
10. Arentz M, Yim E, Klaff L, Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020. doi: 10.1001/jama.2020.4326 32191259
11. Ferrario CM, Jessup J, Chappell MC, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111 (20): 2605-2610. doi: 10.1161/CIRCULATIONAHA.104.510461 15897343
12. Sommerstein R, Kochen MM, Messerli FH, Gräni C. Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect? J Am Heart Assoc. 2020; 9 (7):
13. Derington CG, King JB, Herrick JS, Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020; 75 (4): 973-981. doi: 10.1161/HYPERTENSIONAHA.119.14360 32148129